These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 35855062)

  • 1. A low proportion of asymptomatic COVID-19 patients with the Delta variant infection by viral transmission through household contact at the time of confirmation in Ibaraki, Japan.
    Ogata T; Tanaka H; Irie F; Nozawa Y; Noguchi E; Seo K; Tanaka E
    Glob Health Med; 2022 Jun; 4(3):192-196. PubMed ID: 35855062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Secondary Attack Rate among Unvaccinated Household Contacts of Coronavirus Disease 2019 Patients with Delta Variant in Japan.
    Ogata T; Tanaka H; Nozawa Y; Mukouyama K; Tanaka E; Osaki N; Noguchi E; Seo K; Wada K
    Int J Environ Res Public Health; 2022 Mar; 19(7):. PubMed ID: 35409572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Transmission of SARS-CoV-2 through contact with a SARS-CoV-2-infected individual in the presymptomatic or asymptomatic state in Japan: A case series].
    Tanaka H; Ogata T; Morisada K; Tanaka S; Yoshida T; Nakanishi H; Misawa A; Nishida T; Tetsu O; Nagata M; Nakazato E
    Nihon Koshu Eisei Zasshi; 2021 Aug; 68(8):550-558. PubMed ID: 33994491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of mRNA COVID-19 Vaccines in Japan during the Nationwide Pandemic of the Delta Variant.
    Akaishi T; Kushimoto S; Katori Y; Sugawara N; Igarashi K; Fujita M; Kure S; Takayama S; Abe M; Kikuchi A; Ishizawa K; Abe Y; Imai H; Inaba Y; Iwamatsu-Kobayashi Y; Nishioka T; Onodera K; Ishii T
    Tohoku J Exp Med; 2022 May; 257(1):1-6. PubMed ID: 35354690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in Transmission between SARS-CoV-2 Alpha (B.1.1.7) and Delta (B.1.617.2) Variants.
    Trobajo-Sanmartín C; Martínez-Baz I; Miqueleiz A; Fernández-Huerta M; Burgui C; Casado I; Baigorría F; Navascués A; Castilla J; Ezpeleta C
    Microbiol Spectr; 2022 Apr; 10(2):e0000822. PubMed ID: 35412379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rapid screening assay for L452R and T478K spike mutations in SARS-CoV-2 Delta variant using high-resolution melting analysis.
    Aoki A; Adachi H; Mori Y; Ito M; Sato K; Okuda K; Sakakibara T; Okamoto Y; Jinno H
    J Toxicol Sci; 2021; 46(10):471-476. PubMed ID: 34602531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transmission Dynamics of the Delta Variant of SARS-CoV-2 Infections in South Korea.
    Hwang H; Lim JS; Song SA; Achangwa C; Sim W; Kim G; Ryu S
    J Infect Dis; 2022 Mar; 225(5):793-799. PubMed ID: 34865022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A preliminary study on contact tracing & transmission chain in a cluster of 17 cases of severe acute respiratory syndrome coronavirus 2 infection in Basti, Uttar Pradesh, India.
    Kant R; Zaman K; Shankar P; Yadav R;
    Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):95-99. PubMed ID: 32811800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 RNA load and detection rate in exhaled breath condensate collected from COVID-19 patients infected with Delta variant.
    Sawano M; Takeshita K; Ohno H; Oka H
    J Breath Res; 2022 Jun; 16(3):. PubMed ID: 35580553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
    Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
    Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Household Severe Acute Respiratory Syndrome Coronavirus 2 Transmission and Children: A Network Prospective Study.
    Soriano-Arandes A; Gatell A; Serrano P; Biosca M; Campillo F; Capdevila R; Fàbrega A; Lobato Z; López N; Moreno AM; Poblet M; Riera-Bosch MT; Rius N; Ruiz M; Sánchez A; Valldepérez C; Vilà M; Pineda V; Lazcano U; Díaz Y; Reyes-Urueña J; Soler-Palacín P;
    Clin Infect Dis; 2021 Sep; 73(6):e1261-e1269. PubMed ID: 33709135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral Load Among Vaccinated and Unvaccinated, Asymptomatic and Symptomatic Persons Infected With the SARS-CoV-2 Delta Variant.
    Acharya CB; Schrom J; Mitchell AM; Coil DA; Marquez C; Rojas S; Wang CY; Liu J; Pilarowski G; Solis L; Georgian E; Belafsky S; Petersen M; DeRisi J; Michelmore R; Havlir D
    Open Forum Infect Dis; 2022 May; 9(5):ofac135. PubMed ID: 35479304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronavirus disease 2019 transmission and symptoms in young children during the severe acute respiratory syndrome coronavirus 2 Delta variant and Omicron variant outbreaks.
    Akaishi T; Ishii T
    J Int Med Res; 2022 May; 50(5):3000605221102079. PubMed ID: 35619217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring secondary SARS-CoV-2 transmission from asymptomatic cases using contact tracing data.
    Nakajo K; Nishiura H
    Theor Biol Med Model; 2021 Jul; 18(1):12. PubMed ID: 34271962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study.
    Jing QL; Liu MJ; Zhang ZB; Fang LQ; Yuan J; Zhang AR; Dean NE; Luo L; Ma MM; Longini I; Kenah E; Lu Y; Ma Y; Jalali N; Yang ZC; Yang Y
    Lancet Infect Dis; 2020 Oct; 20(10):1141-1150. PubMed ID: 32562601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Epidemic Characteristics of the Novel Coronavirus Delta Variant in Guangzhou and Grid Crowd Management Based on Public Security Forensic Perspective].
    Liu C; Liu CH; Chen L; Liang XM; Wu J; Peng C; Shi H; Huang LT
    Fa Yi Xue Za Zhi; 2021 Aug; 37(4):527-532. PubMed ID: 34726007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 Delta Variant in Jingmen City, Hubei Province, China, 2021: Children Susceptible and Vaccination Breakthrough Infection.
    Li D; Li AE; Li ZQ; Bao Y; Liu T; Qin XR; Yu XJ
    Front Microbiol; 2022; 13():856757. PubMed ID: 35495649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cluster of Severe Acute Respiratory Syndrome Coronavirus 2 Infections Linked to Music Clubs in Osaka, Japan.
    Sugano N; Ando W; Fukushima W
    J Infect Dis; 2020 Oct; 222(10):1635-1640. PubMed ID: 32840606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in Clinical Characteristics Between Delta Variant and Wild-Type SARS-CoV-2 Infected Patients.
    Hu Z; Huang X; Zhang J; Fu S; Ding D; Tao Z
    Front Med (Lausanne); 2021; 8():792135. PubMed ID: 35047533
    [No Abstract]   [Full Text] [Related]  

  • 20. Increase in Viral Load in Patients With SARS-CoV-2 Delta Variant Infection in the Republic of Korea.
    Kim JM; Rhee JE; Yoo M; Kim HM; Lee NJ; Woo SH; Jo HJ; Kwon D; Lee S; Yoo CK; Kim EJ
    Front Microbiol; 2022; 13():819745. PubMed ID: 35308391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.